Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Dyameo logo — company profile

Dyameo

Founded 2017 France France 8 employees Seed Total: $1.00M Biotechnology, Health Care +1

General Information

Company Name Dyameo
Founded Year 2017
Location France France
Employees 8
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Dyameo. To contact Dyameo, visit dyameo.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Dyameo

Dyameo is a biotechnology and health care startup in France founded in 2017. The company focuses on research and development in the field of medical devices, specifically designing probes to aid in the in-vivo diagnosis of cancer cells. The €1.00M Seed Round investment on 22 November 2021 was led by MEDEVICE Capital and AQUITI Gestion. Dyameo's innovative medical device aims to provide a simple, clear, and instantaneous answer to the question "Are these cells cancerous?" This breakthrough solution is designed to differentiate cancerous cells at an early stage during endoscopic examinations.

Taxonomy: MedTech, Cancer Diagnosis, In-Vivo Diagnostic Tools, Research & Development, Endoscopic Probes, Cancer Cell Detection, Cellular Analysis, Biomedical Innovation

Services & Products

Development of in vitro medical diagnostic devices for aiding surgeons in identifying tissue boundaries during tumor removal surgeries.

Target Customers

Surgeons healthcare professionals and medical facilities performing tumor removal surgeries.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €1.00M 2
MEDEVICE Capital AQUITI Gestion
MEDEVICE Capital, AQUITI Gestion
22 Nov 2021

Dyameo Alternatives & Competitors

View All Alternatives
Dyameo vs
Vivid Microscopy
Vivid Microscopy United States

Fluorescent Probes to Detect Oxidative Stress

2 employees
Biotechnology, Health Care
Dyameo vs
Miftek Corporation
Miftek Corporation United States

Single photon array technology transforming light detection

Grant
18 employees
Biotechnology, Health Care
Dyameo vs
Endofotonics
Endofotonics Singapore

Identifying Early-stage Cancers Through In vivo Molecular Diagnosis

Series B
4 employees
Biotechnology, Health Care
View all alternatives

FAQ About Dyameo

Dyameo est une société de recherche & développement dans le domaine des dispositifs médicaux qui conçoit des sondes d'aide au diagnostic de cellules cancéreuses in-vivo. Ce dispositif médical, permet de répondre à la question: "Ces cellules sont-elle cancéreuses?", et cela de manière simple, claire...
Dyameo was founded in 2017.
Dyameo is headquartered in France.
Dyameo operates in Biotechnology, Health Care and Medical Devices. Its work centres on MedTech, Cancer Diagnosis, In-Vivo Diagnostic Tools and Research & Development. Its customers include Surgeons, healthcare professionals and and medical facilities performing tumor removal surgeries..
Dyameo has approximately 8 employees.
Dyameo has completed 1 funding round, raising a total of $1.00M. The latest funding stage is Seed.
Dyameo offers: Development of in vitro medical diagnostic devices for aiding surgeons in identifying tissue boundaries during tumor removal surgeries..
Top alternatives and competitors to Dyameo include Vivid Microscopy, Miftek Corporation, Endofotonics, Kozhnosys, Sampling Human. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Dyameo and Vivid Microscopy are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Dyameo, https://bouncewatch.com/company/dyameo, updated 7 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes